plasma rich fibrin
Biologicalexperimental
Clinical trial activity
5 trials · 7 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Jan 20, 2021 (NCT04824898)
Timeline
2020s
- Jan 1, 2021
Earliest Phase 1 Sponsor(trial)
Mechanism of action
- FibrinogenSupplementation
Fibrinogen supplementation
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06914193 | N/A | Apr 1, 2025 | Beijing Fangshan District Liangxiang Hospital, Capital Medical University, Hengshui People's Hospital |
| NCT06790758 | N/A | Jan 25, 2025 | Tanta University |
| NCT06790745 | N/A | Jan 25, 2025 | Tanta University |
| NCT06347640 | N/A | Apr 1, 2023 | Jordan University, King Abdullah Medical City |
| NCT04824898 | Phase 1 | Jan 20, 2021 | Ain Shams University |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (7)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Tanta University | Academic/Hospital | 2 | 2 | 1 | 2025 |
| Ain Shams University | Academic/Hospital | 1 | 1 | 1 | 2021 |
| Beijing Fangshan District Liangxiang Hospital | Academic/Hospital | 1 | 0 | 1 | 2025 |
| Capital Medical University | Academic/Hospital | 1 | 1 | 1 | 2025 |
| Hengshui People's Hospital | Academic/Hospital | 1 | 0 | 1 | 2025 |
| Jordan University | Academic/Hospital | 1 | 0 | 1 | 2023 |
| King Abdullah Medical City | Academic/Hospital | 1 | 1 | 1 | 2023 |
7 organizations
Page 1 / 1